As Fauci said there would be an ethical obligation to let the placebo group know due to over whelming efficiency.
The quote was regarding Remdesivir but that quote will apply to others in the COVID space and if the interim trial results of Rem-L are anything like the EAP results then I'd expect a similar outcome, I wouldn't be surprised if this happens with Rem-L these are unprecedented times so nothing is off the table in these circumstances imo
Cell Therapy News/Articles, page-2970
-
- There are more pages in this discussion • 15,304 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.005(0.36%) |
Mkt cap ! $1.581B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.42 | $1.38 | $4.391M | 3.156M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 48253 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 32922 | 2 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |